Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Low calcidiol predicted high-grade calcification independently (OR = 0.57 [95% CI = 0.36 to 0.90]; p = 0.013) along with ST-elevation myocardial infarction (OR = 0.38 [95%CI = 0.19 to 0.78]; p = 0.006), diabetes (OR = 2.35 [95%CI = 1.11 to 4.98]; p = 0.028) and age (OR = 1.37 [95%CI = 1.18 to 1.59]; p<0.001).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

For the SS study patients were divided in SS<14 and SS≥14.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease

Study design awaiting verification · PLoS ONE · 2016

Original publication title

Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease

Roberto Martín-Reyes; Juan Antonio Franco-Peláez; Óscar Lorenzo; María Luisa González-Casaus; Ana María Pello; Álvaro Aceña; Rocío Carda; José Luis Martín-Ventura; Luis Blanco-Colio; María Luisa Martín-Mariscal; Juan Martínez-Milla; Ricardo Villa-Bellosta; Antonio Piñero; Felipe Navarro; Jesús Egido; José Tuñón

© 2016 Martín-Reyes et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

MCP-1 and NT-proBNP are independent predictors of SS, while low calcidiol plasma levels are associated with CAC. More studies are needed to confirm these data.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background and Objectives

We investigated the relationship of the Syntax Score (SS) and coronary artery calcification (CAC), with plasma levels of biomarkers related to cardiovascular damage and mineral metabolism, as there is sparse information in this field.

Source: Background and Objectives

Abstract: What methods does the paper describe?

We studied 270 patients with coronary disease that had an acute coronary syndrome (ACS) six months before. Calcidiol, fibroblast growth factor-23, parathormone, phosphate and monocyte chemoattractant protein-1 [MCP-1], high-sensitivity C-reactive protein, galectin-3, and N-terminal pro-brain natriuretic peptide [NT-proBNP] levels, among other biomarkers, were determined. CAC was assessed by coronary angiogram as low-grade (0 to 1) and high-grade (2 to 3) calcification, measured with a semiquantitative scale ranging from 0 (none) to 3 (severe). For the SS study patients were divided in SS<14 and SS≥14.

Multivariate linear and logistic regression analyses were performed.

Source: Methods

Abstract: Results

MCP-1 predicted independently the SS (RC = 1.73 [95%CI = 0.08 to 3.39]; p = 0.040), along with NT-proBNP (RC = 0.17 [95%CI = 0.05 to 0.28]; p = 0.004), male sex (RC = 4.15 [95%CI = 1.47 to 6.83]; p = 0.003), age (RC = 0.13 [95%CI = 0.02 to 0.24]; p = 0.020), hypertension (RC = 3.64, [95%CI = 0.77 to 6.50]; p = 0.013), hyperlipidemia (RC = 2.78, [95%CI = 0.28 to 5.29]; p = 0.030), and statins (RC = 6.12 [95%CI = 1.28 to 10.96]; p = 0.013). Low calcidiol predicted high-grade calcification independently (OR = 0.57 [95% CI = 0.36 to 0.90]; p = 0.013) along with ST-elevation myocardial infarction (OR = 0.38 [95%CI = 0.19 to 0.78]; p = 0.006), diabetes (OR = 2.35 [95%CI = 1.11 to 4.98]; p = 0.028) and age (OR = 1.37 [95%CI = 1.18 to 1.59]; p<0.001).

During follow-up (1.79 [0.94 to 2.86] years), 27 patients developed ACS, stroke, or transient ischemic attack. A combined score using SS and CAC predicted independently the development of the outcome.

Source: Results

Abstract: Conclusions

MCP-1 and NT-proBNP are independent predictors of SS, while low calcidiol plasma levels are associated with CAC. More studies are needed to confirm these data.

Source: Conclusions
Authors’ abstract

Background and Objectives

We investigated the relationship of the Syntax Score (SS) and coronary artery calcification (CAC), with plasma levels of biomarkers related to cardiovascular damage and mineral metabolism, as there is sparse information in this field.

Methods

We studied 270 patients with coronary disease that had an acute coronary syndrome (ACS) six months before. Calcidiol, fibroblast growth factor-23, parathormone, phosphate and monocyte chemoattractant protein-1 [MCP-1], high-sensitivity C-reactive protein, galectin-3, and N-terminal pro-brain natriuretic peptide [NT-proBNP] levels, among other biomarkers, were determined. CAC was assessed by coronary angiogram as low-grade (0 to 1) and high-grade (2 to 3) calcification, measured with a semiquantitative scale ranging from 0 (none) to 3 (severe). For the SS study patients were divided in SS<14 and SS≥14.

Multivariate linear and logistic regression analyses were performed.

Results

MCP-1 predicted independently the SS (RC = 1.73 [95%CI = 0.08 to 3.39]; p = 0.040), along with NT-proBNP (RC = 0.17 [95%CI = 0.05 to 0.28]; p = 0.004), male sex (RC = 4.15 [95%CI = 1.47 to 6.83]; p = 0.003), age (RC = 0.13 [95%CI = 0.02 to 0.24]; p = 0.020), hypertension (RC = 3.64, [95%CI = 0.77 to 6.50]; p = 0.013), hyperlipidemia (RC = 2.78, [95%CI = 0.28 to 5.29]; p = 0.030), and statins (RC = 6.12 [95%CI = 1.28 to 10.96]; p = 0.013). Low calcidiol predicted high-grade calcification independently (OR = 0.57 [95% CI = 0.36 to 0.90]; p = 0.013) along with ST-elevation myocardial infarction (OR = 0.38 [95%CI = 0.19 to 0.78]; p = 0.006), diabetes (OR = 2.35 [95%CI = 1.11 to 4.98]; p = 0.028) and age (OR = 1.37 [95%CI = 1.18 to 1.59]; p<0.001).

During follow-up (1.79 [0.94 to 2.86] years), 27 patients developed ACS, stroke, or transient ischemic attack. A combined score using SS and CAC predicted independently the development of the outcome.

Conclusions

MCP-1 and NT-proBNP are independent predictors of SS, while low calcidiol plasma levels are associated with CAC. More studies are needed to confirm these data.

Publication and source details

Original title: Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease

Roberto Martín-Reyes; Juan Antonio Franco-Peláez; Óscar Lorenzo; María Luisa González-Casaus; Ana María Pello; Álvaro Aceña; Rocío Carda; José Luis Martín-Ventura; Luis Blanco-Colio; María Luisa Martín-Mariscal; Juan Martínez-Milla; Ricardo Villa-Bellosta; Antonio Piñero; Felipe Navarro; Jesús Egido; José Tuñón

PLoS ONE · 2016

Competing Interests: The authors have declared that no competing interests exist.

Conceived and designed the experiments: RMR JAFP. Analyzed the data: RMR JAFP JT. Wrote the paper: RMR JAFP ÓL MLGC AMP ÁA RC JLMV LBC MLMM JMM RVB AP FN JE JT.

* E-mail: rmartinreyes@yahoo.es
© 2016 Martín-Reyes et al2016Martín-Reyes et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.This work was supported by grants from Fondo de Investigaciones Sanitarias [PI14/1567, PI14/00386, PIE13/00051], Spanish Society of Cardiology; Spanish Heart Foundation; Instituto de Salud Carlos III FEDER [FJD biobank grant RD09/0076/00101]; and AbbVie Laboratories.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T09:27:59.466011+00:00

DOI: 10.1371/journal.pone.0152816 · PMC4865225